9 Drugs Approved for Primary Care: Q2 2025

As another quarter rounds out, a new batch of drugs have been approved by the US FDA for conditions often seen in primary care. Above, find details on the first dihydroergotamine nasal powder product to be approved for the acute treatment of migraine in adults, the first targeted therapy approved for chronic spontaneous urticaria (CSU) in more than a decade, and 7 more.